Tag Archives: VC exits

Biotech’s Paradox: A Robustly Valued, Highly Active, And Seemingly Terrible IPO Market
July 14, 2016

After five very strong years, biotech as a sector has struggled to catalyze positive investor sentiment so far for the past twelve months. In a disastrous start to the year, the NASDAQ Biotech Index shed 30% in just the first

Leave a comment